Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac (Q46522531)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac |
scientific article published in June 2005 |
Statements
1 reference
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac (English)
1 reference
Roberto Giugliani
1 reference
John J Hopwood
1 reference
Paul Harmatz
1 reference
David Ketteridge
1 reference
Natalie Guffon
1 reference
Elisa Leão Teles
1 reference
M Clara Sá Miranda
1 reference
Zi-Fan Yu
1 reference
Stuart J Swiedler
1 reference
MPS VI Study Group
1 reference
1 June 2005
1 reference
1 reference
115
1 reference
e681-9
1 reference
6
1 reference
Identifiers
1 reference
1 reference